Skip to main content
. 2022 Aug 9;6(10):2925–2936. doi: 10.1002/hep4.2045

FIGURE 2.

FIGURE 2

Pooled estimates of sensitivity at 90% fixed‐target specificity for each modality and comparisons to mt‐HBT in any stage HCC and early stage HCC surveillance. Data show 95% CrI in black and 95% predictive intervals in red. AFP, alpha‐fetoprotein; CrI, credible interval; HCC, hepatocellular carcinoma; mt‐HBT, multitarget hepatocellular carcinoma blood test; Post PR, posterior probability; SUCRA, surface under cumulative ranking curve; US, ultrasound; US+AFP, ultrasound plus alpha‐fetoprotein.